Back
Monopar Therapeutics Stock Predictions
Missed Airbnb? Your Next Chance Could Be Sitting In Your Pocket
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
31
MNPR
Monopar Therapeutics
Last Price:
$30.03
Seasonality Move:
-28.14%
7 Day Trial
ALL ACCESS PASS
$
7
The Recession-Proof Asset in Your Pocket
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.Monopar Therapeutics Stock Forecast
-
Over the next 52 weeks, Monopar Therapeutics has on average historically risen by 72.7% based on the past 5 years of stock performance.
-
Monopar Therapeutics has risen higher in 1 of those 5 years over the subsequent 52-week period, corresponding to a historical accuracy of 20%
-
Is Monopar Therapeutics Stock Undervalued?The current Monopar Therapeutics [MNPR] share price is $30.90. The Score for MNPR is 31, which is 38% below its historic median score of 50, and infers higher risk than normal.
-
MNPR is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
Will Monopar Therapeutics Stock Go Up Next Year?
-
Over the next 52 weeks, Monopar Therapeutics has on average historically risen by 72.7% based on the past 5 years of stock performance.
Monopar Therapeutics Stock Rating
Sell
31
Monopar Therapeutics (MNPR)
is a Sell
Is Monopar Therapeutics overpriced?
-
Monopar Therapeutics has risen higher in 1 of those 5 years over the subsequent 52-week period, corresponding to a historical accuracy of 20%
Monopar Therapeutics Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
monopartx.com
52-Week Data
52-Week High:
54.30
52-Week Low:
1.72
Prediction Charts
Market Cap:
163.1M
Price in USD:
30.90
Volume:
17.8K
Beta:
1.37
Technical Analysis
SMA50:
34.67
SMA100:
26.44
SMA200:
15.02
52-Wk Change:
648.18%
Stock Predictions
-
Is Monopar Therapeutics stock public?Yes, Monopar Therapeutics is a publicly traded company.
-
What is the Monopar Therapeutics stock quote today?The Monopar Therapeutics stock price is 30.90 USD today.
-
How to buy Monopar Therapeutics stock online?You can buy Monopar Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Feb-19 | 43.68 | 44.39 | 44.39 | 40.18 |
| Feb-20 | 44.39 | 40.97 | 45.60 | 38.80 |
| Feb-21 | 40.36 | 40.06 | 44.16 | 38.98 |
| Feb-25 | 35.00 | 31.11 | 35.28 | 31.09 |
| Feb-26 | 30.89 | 31.29 | 34.00 | 30.01 |
| Feb-27 | 31.42 | 30.24 | 33.40 | 30.22 |
| Feb-28 | 30.00 | 36.04 | 36.04 | 29.40 |
| Mar-3 | 36.16 | 30.93 | 37.25 | 30.84 |
| Mar-4 | 30.55 | 31.83 | 31.83 | 28.53 |
| Mar-5 | 31.75 | 30.75 | 32.29 | 29.26 |
| Mar-6 | 29.42 | 30.92 | 31.69 | 28.65 |
| Mar-7 | 30.59 | 28.44 | 30.86 | 27.81 |
| Mar-11 | 27.34 | 29.28 | 31.29 | 27.34 |
| Mar-12 | 30.51 | 30.90 | 34.11 | 30.20 |
Monopar Therapeutics Earnings
Monopar Therapeutics Earnings Report: Per Share Monopar Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.
Monopar Therapeutics Forecast Revenue Growth
Monopar Therapeutics Stock Analysis: Historical quarterly revenues per share for Monopar Therapeutics and historical quarterly revenue growth:
-
Analysts estimate an earnings decrease this quarter of $0.50 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.70 per share, and an increase next year of $2.24 per share.
* Monopar Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.